Skip to main content
Erschienen in: Der Diabetologe 6/2016

23.08.2016 | Typ-2-Diabetes | Journal Club

Auswirkungen von Liraglutid auf die Hirnaktivität

verfasst von: Dr. M. Jecht

Erschienen in: Die Diabetologie | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Auszug

Farr OM, Sofopoulos M, Tsoukas MA et al. (2016) GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial. Diabetologia 59:954–965 …
Literatur
1.
Zurück zum Zitat Schlögl H et al (2013) Exenatide-induced reduction in energy intake is associated with increase in hypothalamic connectivity. Diabetes Care 36:1933–1940CrossRefPubMedPubMedCentral Schlögl H et al (2013) Exenatide-induced reduction in energy intake is associated with increase in hypothalamic connectivity. Diabetes Care 36:1933–1940CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C (1997) Distribution of glucagon-like peptide-1 and other preproglucagonderived peptides in the rat hypothalamus and brainstem. Neuroscience 77:257–270CrossRefPubMed Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C (1997) Distribution of glucagon-like peptide-1 and other preproglucagonderived peptides in the rat hypothalamus and brainstem. Neuroscience 77:257–270CrossRefPubMed
3.
Zurück zum Zitat Hunter K, Holscher C (2012) Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. BMC Neurosci 13:33CrossRefPubMedPubMedCentral Hunter K, Holscher C (2012) Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. BMC Neurosci 13:33CrossRefPubMedPubMedCentral
4.
5.
Zurück zum Zitat Sisley S, Gutierrez-Aguilar R, Scott M, D’Alessio DA, Sandoval DA, Seeley RJ (2014) Neuronal GLP1R mediates liraglutide s anorectic but not glucose-lowering effect. J Clin Invest 124:2456–2463CrossRefPubMedPubMedCentral Sisley S, Gutierrez-Aguilar R, Scott M, D’Alessio DA, Sandoval DA, Seeley RJ (2014) Neuronal GLP1R mediates liraglutide s anorectic but not glucose-lowering effect. J Clin Invest 124:2456–2463CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Heppner KM, Kirigiti M, Secher A et al (2015) Expression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain. Endocrinology 156:255–267CrossRefPubMed Heppner KM, Kirigiti M, Secher A et al (2015) Expression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain. Endocrinology 156:255–267CrossRefPubMed
7.
Zurück zum Zitat Wang XF, Liu JJ, Xia J, Liu J, Mirabella V, Pang ZP (2015) Endogenous glucagon-like peptide-1 suppresses high-fat food intake by reducing synaptic drive onto mesolimbic dopamine neurons. Cell Rep 12:726–733CrossRefPubMedPubMedCentral Wang XF, Liu JJ, Xia J, Liu J, Mirabella V, Pang ZP (2015) Endogenous glucagon-like peptide-1 suppresses high-fat food intake by reducing synaptic drive onto mesolimbic dopamine neurons. Cell Rep 12:726–733CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Pyke C, Heller RS, Kirk RK et al (2014) GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody. Endocrinology 155:1280–1129CrossRefPubMed Pyke C, Heller RS, Kirk RK et al (2014) GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody. Endocrinology 155:1280–1129CrossRefPubMed
Metadaten
Titel
Auswirkungen von Liraglutid auf die Hirnaktivität
verfasst von
Dr. M. Jecht
Publikationsdatum
23.08.2016
Verlag
Springer Berlin Heidelberg
Schlagwörter
Typ-2-Diabetes
Liraglutid
Erschienen in
Die Diabetologie / Ausgabe 6/2016
Print ISSN: 2731-7447
Elektronische ISSN: 2731-7455
DOI
https://doi.org/10.1007/s11428-016-0133-2

Weitere Artikel der Ausgabe 6/2016

Der Diabetologe 6/2016 Zur Ausgabe

Mitteilungen des BDE

Mitteilungen des BDE

Praxisempfehlungen der Deutschen Diabetes Gesellschaft

Kurz, prägnant und aktuell: Die Praxisempfehlungen der Deutschen Diabetes Gesellschaft.